Global Aortic and Peripheral Vascular Interventional Therapy Product Market Strategic Research Report

Scope of the Report

The global Aortic and Peripheral Vascular Interventional Therapy Product market size is predicted to grow from US$ 10,932 million in 2025 to US$ 18,061 million in 2032; it is expected to grow at a CAGR of 7.6% from 2026 to 2032.

Aortic and Peripheral Vascular Interventional Therapy Products refer to a range of medical devices and integrated solutions used for the diagnosis and treatment of aortic and peripheral vascular diseases through minimally invasive, image-guided procedures. These products include aortic stent grafts, peripheral vascular stents, balloon catheters, guidewires and catheter systems, thrombectomy devices, and drug-coated devices. They are primarily used to treat conditions such as aortic aneurysms, aortic dissections, peripheral arterial stenosis or occlusions, and venous thrombosis. The core principle involves delivering devices precisely to target lesions via percutaneous vascular access to reconstruct vessels, exclude diseased segments, or restore blood flow. Compared with traditional open surgery, these products offer reduced trauma, faster recovery, and expanding clinical indications, representing a key evolution toward minimally invasive, precise, and integrated cardiovascular therapies.The average gross profit margin of this product is 73%.

The increasing incidence of aortic and peripheral vascular diseases, driven by aging populations and the widespread prevalence of hypertension and atherosclerosis, is supporting steady growth in interventional treatment demand. Clinical practices are shifting from open surgery to minimally invasive interventions, accelerating the adoption of endovascular aortic repair and peripheral interventions. Meanwhile, continuous advancements in stent graft technologies, low-profile delivery systems, and imaging navigation have significantly improved procedural safety and success rates. In addition, ongoing improvements in healthcare systems and rising affordability in emerging markets provide long-term growth momentum. This field is characterized by high technical complexity, with strict requirements for product design, material performance, and clinical validation, leading to long development cycles and substantial investment. Aortic intervention products, in particular, present high entry barriers, with leading multinational companies dominating the high-end segment, while local players face both technological and branding challenges. Policy factors such as centralized procurement and healthcare cost control exert pricing pressure and compress profit margins. Furthermore, complex anatomical structures and high-risk cases increase dependence on physician expertise, introducing uncertainty in clinical adoption. Clinical demand is evolving toward precision and personalization, placing higher requirements on device adaptability, long-term durability, and ease of operation. In aortic disease treatment, there is a growing trend toward early intervention and standardized management, driving demand for high-performance stent grafts. In the peripheral vascular field, greater emphasis is placed on managing long lesions and reducing restenosis. Healthcare services are gradually extending to primary care settings, increasing demand for standardized and user-friendly products. Additionally, rising needs in venous diseases and complex vascular reconstruction are driving further segmentation of product offerings. Upstream materials mainly include metallic materials, polymer materials, and biomedical coating materials, with nitinol, cobalt-chromium alloys, and polytetrafluoroethylene being key foundational materials. These materials directly determine radial strength, flexibility, and long-term stability, while also influencing biocompatibility and safety. Currently, high-end raw materials still partially rely on imports, making supply chain stability and cost control critical concerns. With advancements in material technologies and the acceleration of localization, domestic substitution is increasing, although higher requirements for quality control and manufacturing consistency are emerging.

This report presents a comprehensive overview of the global Aortic and Peripheral Vascular Interventional Therapy Product market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Stent
• Catheter
• Guidewire
• Sheath
• Vena Cava Filter
• Other

Segment by Diseases

• Arterial Diseases
• Venous Diseases

Segment by Material

• Metallic Devices
• Polymer Devices

Segment by Application

• Hospital
• Clinic
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Aortic and Peripheral Vascular Interventional Therapy Product market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospital, Clinic, Other evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact